Conference Program

All times are scheduled in EST.

Conference Program PDF
Research Briefs PDF
Thursday, October 21st, 2021
Track 1
Track 2
Track 3
Industry Track
10:30

Welcome and Introductions

11:00
Plenary: Honouring the Strengths of First Nations in Substance Use Challenges
Carol Hopkins, Executive Director of the Thunderbird Partnership Foundation
12:00

15 minute BREAK

12:15
Track 1:

Workshop

The Pandemic Pivot to Increase Access to Care through Digital Health Solutions: Developing and Implementing a RAAM Digital Front Door and Virtual Concurrent Disorders Day Program

Workshop

The Concerning Trajectory of Opioid Use Disorder and Opportunities for Intervention: Lessons Learned from Clinical Practice and Research in the Fentanyl Era
Track 2:

Symposium

Current Challenges with Comorbid Psychiatric and Substance Use Disorders
Track 3:

Workshop

Complexities in Adolescent Substance Use- Evidence Informed and Creative Approaches to Care

Workshop

Buprenorphine Extended-Release Monthly Injections: The First 100 Patients (London, Canada)
2:15
Track 1 & 2:

1 hour BREAK

Track 3:

Mentor Lunch (Trainees)

Industry Track:

Indivior Industry Session

Micro vs. Macro: Moving the Needle, A New Framework for the Canadian Opioid Crisis
3:15
Track 1:

Workshop

Developing Medical Education for the Next Generation of Canadian Physicians on Pain Management
Track 2:

Symposium

Implementing an Opioid Use Disorder/Buprenorphine Strategy in the Emergency Department
Track 3:

Trainee Session

Addiction Medicine Complex Case Discussion Session: Ethical Cases
4:30

15 minute BREAK

4:45
Track 1:

Symposium

Partnering with Indigenous Elders at the Kilala Lelum Health Centre: Rebuilding the Primary Care System to Improve Care for Indigenous People Living with Opiate Use Disorder - Exploring Staff and Provider Experiences
Track 2:

Workshop

Addiction is Addiction: How to Put the Concepts into Practice?
Track 3:

Trainee Session

Addiction Medicine Complex Case Discussion Session: Medical cases
5:45

30 minute BREAK

6:15
Trivia Night
8:00

End

Friday, October 22nd, 2021
Track 1
Track 2
Track 3
Industry Track
10:45

Welcome and Introductions

11:00
Plenary: Harm Reduction and Recovery: The Basis for Peace in Addiction’s Civil War
Julian M. Somers, Professor of Simon Fraser University
12:00

15 minute BREAK

12:15
Plenary: The Power of Resilience
Mamta Gautam, Psychiatrist, Consultant, Coach, Author and Speaker
1:15
Track 1:
Workshop
The Interface Between Substance Use Disorders and Psychiatric Conditions: A Debate

1 hour BREAK

2:15
Track 1:
CCSA Symposium
Updating Canada's Low Risk Alcohol Drinking Guidelines
CCSA Symposium
Not Too Much, Not Too Often and Not Too Many: The Results of the First Large Scale, International Project to Develop Lower Risk Gambling Guidelines
Track 2:
Symposium
The Forgotten Public Health Crisis: Alcohol Use Disorder in the ED
Symposium
Recovery is Not a Swear Word
Track 3:
Workshop
Methadone Treatment for People Who Use Fentanyl: Implementing the META: PHI Recommendations
3:45

15 minute BREAK

4:00
Track 1:
Workshop
M-SSTEP Project (McMaster’s Substance Support Through Education and Partnership): The Development of a Clinical Resource for the Identification and Treatment of Adolescent Substance Withdrawal
Workshop
Buprenorphine Formulations in Pregnancy: Safety and Efficacy Considerations for Canadians
Track 2:
Workshop
Opioid Agonist Therapy: A Synthesis of Canadian Guidelines for Treating Opioid Use Disorder
Track 3:
Safe Supply Panel Discussion
5:00
Networking Power Hour

Meet new addiction medicine colleagues during this casual speed networking event. Attendees will be given the opportunity to connect with colleagues in a Zoom-based setting, getting to know the voices that are shaping the landscape of addiction medicine through informal, 10-minute breakout chats.

6:00

End

Saturday, October 23rd, 2021
Track 1
Track 2
Track 3
Industry Track
10:45

Welcome and Introductions

11:00
Plenary: Neurobiology of Addiction, Pain and Hyperkatifeia: The Negative Emotional Side of Addiction
George F. Koob, Director of the National Institute on Alcohol Abuse and Alcoholism
12:00

15 minute BREAK

12:15
Track 1:
On-Demand Research Briefs
Track 2:
On-Demand Research Briefs
Track 3:
On-Demand Research Briefs
1:45

1 hour BREAK

Industry Track:

Indivior Breakout Session

A SUBLOCADE ® Educational and Clinical Experiences Live Virtual Event with Katie Dunham
2:45
Track 1:
Symposium
The Whole World is Watching: Improving Cannabis Legalization in Canada and Beyond
Symposium
Social Justice in Health Care: iOAT and Advocacy in Fredericton
Track 2:
Symposium
Breast/Chest Feeding in Patients with Substance Use Disorder, Perinatal Dyad Care
Symposium
Perinatal Dyad Care, Rooming In and Eat, Sleep, Console (ESC) in the Face of the Fentanyl Crisis
Symposium
Injectable Opioid Agonist Therapy Protocol in a Perinatal Acute Care Setting
Track 3:
Distinguished Research Briefs (Selected by Expert Panel)
4:15

15 minute BREAK

4:30
Track 1:
Workshop
Treatment Centres for Addiction: Evidence, Challenges, and Opportunities
Workshop
Learning to Say Yes: Merging Novel Harm Reduction Strategies at the Calgary ODP During COVID-19
Track 2:
Workshop
Using Somatic Techniques to Heal Trauma Underlying Addiction
Workshop
Drifting from Patient-Centred to Patient-Driven Care: What is Driving the Trend?
Track 3:
Workshop
How, When and Under What Circumstances Should Family Members Be Included in Discussions
5:30

Conference Closing

*Please note, this program is subject to change.

Full abstracts for each presentation will be available to registered attendees on the virtual conference platform.

Honouring the Strengths of First Nations in Substance Use Challenges

Carol Hopkins

Carol Hopkins

Executive Director of the Thunderbird Partnership Foundation

Carol Hopkins has been a pioneer in the field of First Nations substance use and mental health for more than 25 years. An Officer in the Order of Canada, she has been at the helm of some of Canada’s most important national initiatives and now works as the Executive Director of the Thunderbird Partnership Foundation, a division of the National Native Addictions Partnership Foundation. She holds an honorary Doctor of Laws degree from Western University, a Master of Social Work from the University of Toronto and a degree in sacred Indigenous Knowledge, equivalent to a PhD in western education systems.

In her 2021 plenary talk, she will provide an expert overview of First Nations methodologies for addressing substance use challenges, relying on Indigenous knowledge and culture-based practices in collaboration with clinical practice. She will discuss the Canadian Research in Substance Misuse (CRISM) study and the results, including a First Nation community-based guideline for addressing opioid and methamphetamine, which supports services for First Nations, by First Nations.

The Pandemic Pivot to Increase Access to Care Through Digital Health Solutions: Developing and Implementing a RAAM Digital Front Door and Virtual Concurrent Disorders Day Program

Workshop

Kelly Suschinsky, Kim Corace, Melanie Willows, Suzanne Bell, Louise Overington, Melissa Webb, Leanne Paisley

In this session, attendees will learn about the development and implementation of a Rapid Access Addiction Medicine (RAAM) clinic digital front door and a virtual concurrent disorders (V-CDU) day program. Participants will also learn to identify practical considerations, obstacles, and strategies when launching novel virtual care services and solutions.

The Concerning Trajectory of Opioid Use Disorder and Opportunities for Intervention: Lessons Learned from Clinical Practice and Research in the Fentanyl Era

Workshop

Leen Naji, Brittany Dennis, Zainab Samaan
After this session participants will be able to summarize current epidemiologic evidence concerning OUD, highlighting significant changes in the demographic and clinical characteristics of opioid-dependent patients. Presenters will discuss implications for risk mitigation and treatment selection, and list lessons learned in one of the largest ongoing prospective cohort studies in Canada, underscoring key study findings over the last 10 years including a summary of the most important risk factors affecting treatment outcomes.

Current Challenges with Comorbid Psychiatric and Substance Use Disorders

Symposium

Dr. David Crockford, Dr. Chris Fraser, Dr. Anees Bahji

This symposium will focus on diagnosing and treating comorbid psychiatric and substance use disorders. Diagnosis, approaches and treatment of comorbid eating and personality disorders in patients presenting for addiction treatment will be explored. Additionally, the findings of a systematic review of cannabis use and bipolar disorder will be presented, highlighting the detrimental impact of cannabis use on the course of bipolar disorder and treatment outcomes.

Complexities in Adolescent Substance Use: Evidence-Informed and Creative Approaches to Care

Workshop

Karen Leslie, Nicholas Chadi, Laurie Horricks, Dzung Vo, Cathy Maser, Eva Moore, Christina Grant, Trish Tulloch, Richard Belanger, Natalie Finner
In this session participants will learn about adolescent-focussed assessment for complex substance use presentations, and discuss enablers and challenges in health systems for the care of this patient population. Presenters will show participants how to apply current evidence for substance use treatment to adolescents experiencing physical and mental health issues related to their substance use.

Buprenorphine Extended-Release Monthly Injections: The First 100 Patients

Workshop

Ken Lee, Dr. Louisa Manon-Bellemare, Dr. Julie Samson

Hear first-hand about the Canadian experience with buprenorphine extended-release monthly injections at an addiction medicine clinic in London, Ontario, Canada. At the close of this session, attendees will be able to summarize the cohort analysis of treatment statistics at the clinic.

Developing Medical Education for the Next Generation of Canadian Physicians on Pain Management, Opioid Stewardship and Substance Use Disorder

Workshop

Lisa Graves, Fran Kirby, Richard van Wylick, Nancy Dalgarno, Klodiana Kolomitro, Jeanne Mulder
Participants will learn about the process of developing an Undergraduate Medical Education (UGME) curriculum, and will learn to recognize the use of the existing curriculum in their own settings.

Implementing an Opioid Use Disorder/Buprenorphine Strategy in the Emergency Department

Symposium

Jennifer Wyman, Elizabeth Shouldice, Larry Nijmeh, Anita Srivastava
In this session participants will be able to choose an appropriate method of buprenorphine initiation, depending on patient and resource factors. Presenters will also discuss how to identify resources, partners and strategies to support implementation of an OUD/buprenorphine pathway in your own emergency department setting.

Addiction Medicine Complex Case Discussion Session: Ethical Cases

Trainee Session

In addiction medicine, we are often faced with complex ethical dilemmas involving people who use substances. By attending this workshop, attendees will be able to formulate an approach to complex addiction medicine cases with a focus on ethical issues that arise in clinical practice. The workshop will be facilitated by a group of multidisciplinary addiction medicine providers who will bring ethically complex cases to the group for discussion and problem-solving. Attendees will spend time in breakout rooms where complex cases will be presented and discussed, and this will be followed by large group discussion.

Partnering with Indigenous Elders at the Kilala Health Centre: Rebuilding the Primary Care System to Improve Care for Indigenous People Living with Opiate Use

Symposium

Dr. David Tu, Leah Walker, Bruce Robinson

By the end of this symposium, participants will be able to demonstrate the importance of partnering with Indigenous Elders in the care for Indigenous peoples.

Talk 1: Exploring Staff and Provider Experiences at the Kilala Lelum Health Centre

By the end of this presentation, participants will be able to describe the Kilala Lelum PCMH+ model of care and understand the experience of working in this unique centre.

Talk 2: Exploring Staff and Provider Experience of Implementing an iOAT Program in an Indigenous Health Centre

By the end of this presentation participants will be able to describe the challenges of providing health care to Indigenous people living with OUD, and to summarize some of the benefits and obstacles to implementing iOAT services.

Talk 3: Improving Outcomes for People Living with Opiate Use Disorder: A Prospective Cohort Study

At the end of this presentation participants will be able to describe the study design, the baseline characteristics of study participants, and the preliminary qualitative findings.

Addiction is Addiction: How To Put the Concepts into Practice?

Workshop

Raju Hajela
In this session, participants will learn how the definition and understanding of addiction has evolved over the last 32 years, during the establishment and development of the Canadian Society of Addiction Medicine. Attendees will practice talking to patients about the primary chronic nature of the disease of addiction, discuss the ABCDE, and understand the biological, psychological, social and spiritual aspects of ongoing recovery.

Addiction Medicine Complex Case Discussion: Medical Cases

Trainee Session

In addiction medicine, we are often faced with complex cases involving people who use substances and have comorbid physical illnesses, but practice guidelines don’t always provide clear protocols for how to manage these cases. By attending this workshop, attendees will be able to formulate an approach to complex addiction medicine cases involving physiological, pharmaceutical, and psychological principles. The workshop will be facilitated by a panel of addiction medicine providers who will bring medically complex cases to the group for discussion and problem-solving. Attendees will spend time in breakout rooms where complex cases will be presented and discussed, and this will be followed by large group discussion.

Harm Reduction and Recovery: The Basis for Peace in Addiction’s Civil War

Julian Somers

Julian M. Somers

Professor of Simon Fraser University

Julian Somers is a distinguished professor at Simon Fraser University and director of the university’s Centre for Applied Research in Mental Health & Addiction. A licenced clinical psychologist, he is a decorated and respected leader in practices that promote recovery from addiction, mental illness and homelessness. He has led major studies examining the effectiveness of interventions, and has developed clinical services for people with limited finances, as well as those in rural and remote regions of Canada. He works closely with people who experience addictions and with government leaders responsible for relevant policies and services. Members of the Somers Research Group have earned local, national, and international awards for research in the public interest and in 2018 Dr. Somers received SFU’s award for Excellence in Supervision in engineering, medical and natural sciences.

The Power of Resilience

mamta Gautam

Mamta Gautam

Psychiatrist, Consultant, Coach, Author and Speaker

Mamta Gautam is an internationally acclaimed psychiatrist, consultant, coach, author and speaker. Known as “the doctor’s doctor,” she has been a pioneer in physician health and wellbeing since 1990. She is the founding director of the University of Ottawa Faculty of Medicine Wellness Program, served as an advisor for the Canadian Medical Association Centre for Physician Health and Wellbeing, and currently chairs the organization’s Burnout Task Force. In the past two decades, she has expanded her work to include physician leadership development to better address system-level factors that impact physician wellness. Dr. Gautam is committed to advancing diversity in medicine, and leadership development for women in medicine. She has served as the Diversity Monitor at the Royal College of Physicians and Surgeons of Canada and developed Momentum, a 6-day retreat for women in medicine. Most recently, she founded The Raft, an online platform for leadership development and community for women physicians.

She is the recipient of numerous prestigious awards for her innovative work to support her physician colleagues, and for her mentoring of women colleagues, and has been awarded Distinguished Fellowships in both the Canadian and American Psychiatric Associations.

In her 2021 plenary talk, Dr. Gautam will explore the power of resilience and provide attendees with practical strategies to manage stress effectively, both in their professional and personal lives. Stress is inherent in medicine, and physicians today are facing unprecedented change, uncertainty and complexity. Healthcare workers are experiencing significant — and possibly enduring — psychological distress. This presentation will help to define and normalize these concerns. It is designed to help understand stress and how to recognize when it turns into distress. Dr. Gautam will address how we may be able to identify others who are struggling, how best to approach students, residents, colleagues or staff to offer help, and to let them know that someone cares.

The Interface Between Substance Use Disorders and Psychiatric Conditions: A Debate

Workshop

The interface between psychiatric disorders and addiction is complex and challenging. For those presenting to addiction treatment, comorbidity is the norm rather than the exception, with more than half having active psychiatric comorbidity. Compared to those with an addictive disorder alone, people with psychiatric comorbidity typically have greater illness severity and worse longitudinal course. Consequently, concurrent conditions are more challenging to treat, with lower treatment retention, increased risk of relapse to either entity, greater psychosocial barriers, higher rates of violence and suicide, and more health services utilization.

This debate will focus on a nuanced topic in the treatment of psychiatric disorder and addiction: the role of involuntary treatment. Members from the CSAM Policy Committee will discuss examples when the Mental Health Act has been applied to mandate compulsory treatment for a substance use disorder or a complication. Other members will summarize findings from a recent policy review examining the implications of involuntary treatment. Finally, there will be a lively discussion highlighting higher-level topics influencing treatment, such as psychiatric nosology (e.g., are substance use disorders psychiatric?), capacity and consent in the context of addiction treatment, the implications of using the mental health act in cases of substance use disorder treatment, and regional differences in addiction treatment across Canada.

Updating Canada's Low Risk Alcohol Drinking Guidelines

Symposium

TBD

In 2020, the Canadian Centre on Substance Use and Addiction received funding from Health Canada to lead an initiative to update Canada’s Low-Risk Alcohol Drinking Guidelines (LRDG). These guidelines help Canadians make informed decisions about alcohol consumption and help stakeholders better communicate alcohol-related harms with their target audiences. This presentation will summarize the process, and present preliminary results of the project.

Not Too Much, Not Too Often and Not Too Many: The Results of the First Large Scale, International Project to Develop Lower Risk Gambling Guidelines

Symposium

TBD

Since 2016, the Canadian Centre on Substance Use and Addiction has led the first large scale international, comprehensive, multimodal project to develop evidence-based Lower-Risk Gambling Guidelines (LRGGs). Borrowing the same collaborative, evidence-driven approach used to develop the nation’s Low Risk Alcohol Drinking Guidelines, the LRGG initiative has produced a workable set of evidence-based quantitative limits on gambling behaviour to help people make informed decisions about their gambling.

This project included collaboration with researchers in eight other countries, analysis of epidemiological data from over 60,000 gamblers, consultation with a pan-Canadian, multi-sectoral advisory committee made up of over 20 members, input from over 10,000 regular gamblers via a national online survey, and qualitative data obtained from focus groups and interviews.

The presentation will unveil the key deliverables from the LRGG project including the lower-risk limits for expenditure, frequency and number of types of games. It will also present a self-assessment quiz, a suite of posters and other knowledge mobilization tools to communicate the guidelines.

The Forgotten Public Health Crisis: Alcohol Use Disorder in the ED

Symposium

Hasan Sheikh
Patients with two or more alcohol-related visits to the emergency department in one year have a high mortality rate. In this session, participants will learn about emergency department interventions to treat alcohol use disorder, including anti-craving medications and the treatment of alcohol withdrawal. Participants will also learn about downstream interventions such as low-barrier rapid access addiction medicine clinics, and upstream policy interventions including minimum alcohol pricing, density of alcohol stores, and purchasing hours.

Recovery is Not a Swear Word

Workshop

Rand Tweed
In this workshop the relationship and pathways between ACE (Adverse Childhood Experiences), SUDs and Recovery with a focus on Recovery Capital, and use of the Recovery Capital Checklist will be discussed. Participants will develop an understanding of these three issues to assist patients in navigating the recovery process and rebuilding neurobiological response to stress, a primary trigger to relapse.

Methadone Treatment for People Who Use Fentanyl: Implementing the META:PHI Recommendations

Workshop

Jennifer Wyman, Mel Kahan, Lisa Bromley, Anita Srivastava, Lori  Regenstreif

Learn about dose initiation and titration strategies to assist patients in reaching an optimal dose of methadone safely and quickly, and develop strategies for more holistic and patient-centered care to promote retention in opiate antagonist therapy.

M-SSTEP Project (McMaster’s Substance Support Through Education and Partnership): The Development of a Clinical Resource for the Identification and Treatment of Adolescent Substance Withdrawal

Workshop

Laurie Horricks NP, Allie Taggart RN, Dr. Andrew Latchman, Dr. Suzanne Turner
Participants will practice the steps in the development and rollout of the M-SSTEP tools, which include a clinical resource guide and a four-step algorithm. Participants will also learn to assess the early results collected in the first six months after the rollout of the M-SSTEP tools.

Buprenorphine Formulations in Pregnancy: Safety and Efficacy Considerations for Canadians

Workshop

Suzanne Turner, Maya Nader, Erin Lurie
This workshop will explore the pregnancy-related safety data available on buprenorphine formulations available in Canada and offer a framework for selecting a buprenorphine formulation in pregnancy.

Opioid Agonist Therapy: A Synthesis of Canadian Guidelines for Treating Opioid Use Disorder

Workshop

Peter Selby, Andrew Johnson, Hema Zbogar
In this session, participants will learn to compare different forms of pharmacotherapy for OUD in real-world settings, and to describe the adaptations to OUD standards in post-pandemic practice.

Safe Supply

Panel Discussion

Dr. Paxton Bach, Dr. Ash Heaslip, Dr. Vincent Lam, Dr. Nick Mathew

Join us for an honest, informed, consensus-building dialogue on safe supply with four respected addiction medicine practitioners working on the front lines of Canada’s ongoing opioid epidemic. Established addiction medicine protocols focus on the person using the substance, with health care providers diagnosing substance use disorders and offering treatment designed to achieve and support individualized outcomes. For many years, addiction medicine practitioners enjoyed a broad consensus around this approach to addiction treatment. That long-held consensus broke down when fentanyl arrived.

Potent and unpredictable, fentanyl — alone and combined with other substances — resulted in a marked increase in non-fatal and fatal overdoses. A number of health care providers began to argue that providing access to a safe supply of drugs would reduce harm, save lives, and more effectively address a toxic drug supply. Today, emerging models of treatment suggest that physicians should provide prescription-grade, high-potency opioids like hydromorphone to people who would otherwise use illicit drugs. Alternative views suggest that inadequate evidence exists to pursue this model and that the model may be associated with additional harms. The debate regarding provision of prescription-grade opioids outside of established OAT models is one of the most important current issues in the addictions landscape. As part of CSAM-SMCA’s strategic goals, we offer a table for discussion to explore this issue and build consensus among Canadian addiction medicine practitioners.

Neurobiology of Addiction, Pain and Hyperkatifeia: The Negative Emotional Side of Addiction

george koob

George F. Koob

Director of the National Institute on Alcohol Abuse and Alcoholism

George Koob is an internationally recognized expert on alcohol, stress, and the neurobiology of alcohol and drug addiction. He is the Director of the National Institute on Alcohol Abuse and Alcoholism where he leads efforts to reduce the public health burden associated with alcohol misuse and oversees a broad portfolio of alcohol research. His work has advanced our understanding of the physiological effects of alcohol and has helped us understand why some people transition from use to misuse to addiction, while others do not. He has authored more than 650 peer-reviewed scientific papers and is a co-author of The Neurobiology of Addiction, a comprehensive textbook reviewing the most critical neurobiology of addiction research conducted over the past 50 years. He has received many prestigious honors and awards for his research, mentorship, and international scientific collaboration.

In his 2021 plenary talk he will explore the neurobiology of hyperkatifeia — the dysphoria, malaise, pain and misery associated with addiction — and consider how emotional pain may help explain the prominent role that alcohol and drugs play in “deaths of despair.”

On-Demand Research Briefs

Research briefs present original research by new or established investigators in any discipline. They are presented as an on-demand, five-minute video summary with a maximum of 10 slides. Selected research briefs will be featured in a live stream during one of three Research Brief Sessions. One of the research brief sessions will highlight submissions by trainees. These moderated sessions will include Q & A with the author of each research brief shown.
See the full list of Research Briefs

The Whole World is Watching: Improving Cannabis Legalization in Canada and Beyond

Symposium

Michael Deviller
In this session participants will become aware of approaches for improving a public health priority for cannabis legalization and of opportunities to implement its components. Cannabis legalization can be improved using a policy model that better reflects a public health priority. There are opportunities to address critical issues such as industry production and retail models, minimum age for use, product promotion practices, consumer protection and holding the cannabis industry accountable to legislative and regulatory provisions.This presentation will be relevant to a number of audiences including healthcare providers attempting to mitigate cannabis-related harms and people concerned aboutcurrent campaigns to legalize other recreational drugs such as psilocybin (magic mushrooms).

Social Justice in Health Care: iOAT and Advocacy in Fredericton, NB

Symposium

TBD

In this session, attendees will learn about River Stone Recovery Centre’s model of treatment for opiate use disorder, which includes oral and injectable opioid agonist treatment, wraparound services, and group medical appointments that save provider time and treat participants as experts in their own lives. This information will be helpful for those considering offering iOAT. Attendees will also learn strategies for advocating for people with substance use disorder in healthcare, housing and programming.

Breast/Chest Feeding in Patients with Substance Use Disorder

Symposium

Heather McEwen, Marie-Noellle Trottier-Boucher
This sessions will discuss the main considerations regarding breastfeeding and chestfeeding in substance-exposed dyads, and learn intrapartum and postpartum HIV management for at-risk dyads.

Perinatal Dyad Care, Rooming In and Eat, Sleep, Console (ESC) in the Face of the Fentanyl Crisis

Symposium

Rob Everett, Patricelli Charissa
In this session participants will learn to treat and manage perinatal substance use in both the mother and newborn.

Injectable Opioid Agonist Therapy Protocol in a Perinatal Acute Care Setting

Workshop

Shanlea Gordon
To our knowledge, the Families in Recovery (FIR) Combined Care Unit Program at BC Women’s Hospital and Health Centre is one of the first inpatient programs in Canada to develop a protocol for the administration of iOAT during pregnancy for persons with severe OUD. In this session, the elements of the newly implemented perinatal iOAT protocol at FIR, developed by a multidisciplinary team of addictions and perinatal specialists, will be presented. Additionally, we will review outcomes, key considerations, and challenges and opportunities of implementing an acute care iOAT protocol in a perinatal setting.

Treatment Centres for Addiction: Evidence, Challenges, and Opportunities

Workshop

Aman Haji, John Koehn
Participants will learn to identify therapeutic initiatives employed by addiction treatment centres — Motivational Interviewing (MI), Motivational Enhancement Therapies (MET), Cognitive Behavioural Therapy (CBT), Dialectical Behvioural Therapy (DBT), Alcoholics Anonymous (AA), Narcotics Anonymous (NA) and Self-Management and Recovery Training (SMART) — some of which have a strong evidence base, and others for which evidence is lacking. Addiction treatment centres have an important role to play to facilitate recovery, though more robust research is required to ensure that evidence-based approaches are integrated into such centres to enhance therapeutic outcomes.

Learning to Say Yes: Merging Novel Harm Reduction Strategies at the Calgary ODP during the COVID-19 Pandemic

Workshop

Cristina Zaganelli, Alison O’Connor, Ronald Lim

Learn about novel harm reduction strategies employed at the iOAT and ODP program in Calgary in response to the double crisis of the COVID-19 pandemic and increasing overdose rates from a toxic drug supply. At the close of this session, participants will be able to recognize opportunities to incorporate multiple services alongside OAT to increase flexibility, reduce barriers and improve access to the most vulnerable and severe OUD patients.

Using Somatic Techniques to Heal Trauma Underlying Addiction

Workshop

Christine Gibson
Learn to identify the connection between addiction and trauma — both the neurophysiology and the pathways to healing — and practice somatic modalities for healing trauma pathways in the brain.

Drifting from Patient-Centred to Patient-Driven Care: What is Driving the Trend?

Workshop

Claudette Chase
Participants will formulate insight to the factors influencing their personal practice style and be able to describe the differences between patient-centred and patient-driven care.

How, When and Under What Circumstances Should Family Members be Included in the Discussions of Capacity and Consent?

Workshop

Oona St-Amant, Angie Hamilton, Barbara Watts, Brynlea Barbeau, Louise White, Monica Hughes
In this session participants will be engaged in a reflective discussion of case scenarios of interviews with family members and discuss the role of family related to decisions of capacity and consent for patients with SUD and concurrent disorders. Presenters will identify the contextual factors that influence clinical decision-making related to family involvement in care, and discuss implications for privacy and family-centred care.